Showing results (201-210 of 373) with videos related to
Sort By:
Pageof 38
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.Nature Communications|April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axisCristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid TumorsChristopher J Sweeney, John D Hainsworth, Ron Bose, et al.The Journal of Clinical Investigation|April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapyYeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2014
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patientsSietske B M Gaykema, Carolien P Schröder, Joanna Vitfell-Rasmussen, et al.The Lancet. Oncology|March 13, 2019
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket studyFunda Meric-Bernstam, Herbert Hurwitz, Kanwal Pratap Singh Raghav, et al.NAR Cancer|June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assayFrancesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.Cancer Discovery|January 11, 2017
APC/C Dysfunction Limits Excessive Cancer Chromosomal InstabilityLaurent Sansregret, James O Patterson, Sally Dewhurst, et al.The Journal of Pathology|October 15, 2013
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomasMarco Gerlinger, Sergio A Quezada, Karl S Peggs, et al.Plos Medicine|December 7, 2016
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineGerald Goh, Ramona Schmid, Kelly Guiver, et al.Pageof 38